Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Founded in 1999 and headquartered in Seoul, South Korea, Selvas AI Inc. is an innovator in artificial intelligence (AI) technologies. Its diverse portfolio of AI solutions includes Selvy Note, an AI voice recorder that transcribes conversations from research, consultations, and meetings; Selvy MediVoice, an AI medical voice recognition system facilitating the creation of medical records during clinical processes; and Selvy SpeechEdu, an AI training platform designed for language education, offering text utilization learning, precise sentence pronunciation accuracy, and advanced phoneme-level phonetic training. Further expanding its AI offerings, Selvas AI Inc. provides odiro for AI voice content generation; Selvy Alrimi, an AI announcement system capable of converting text into broadcast voice for automated, scheduled transmission; and Selvy Checkup, an AI solution for predicting the probability of disease occurrence. Beyond AI, the company also offers OnFit, an IoT-based smart program for managing fitness and membership services; Selpub, a cloud-hosted multimedia eBook platform; and DIODICT, a mobile electronic dictionary. The company, originally incorporated as DIOTEK Co., Ltd., underwent a name change to Selvas AI Inc. in September 2016.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, ove